# China NMPA Drug Inspection - Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. - Shuanghuanglian oral liquid

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/harbin-pharmaceutical-group-sanjing-pharmaceutical-co-ltd/8aaf2927-2b6f-4a3e-8cf4-0856774aa403/
Source feed: China

> China NMPA drug inspection for Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. published March 20, 2020. Drug: Shuanghuanglian oral liquid. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Gansu Provincial Drug Administration Regarding Sampling Inspection Information of Drugs Used for COVID-19 Prevention and Control
- Company Name: Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-20
- Drug Name: Shuanghuanglian oral liquid
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/harbin-pharmaceutical-group-sanjing-pharmaceutical-co-ltd/a207ccbe-f53b-4924-9d66-30d6c899f16b/